These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1766488)

  • 21. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer.
    Załeska J; Pirozynski M; Kwiek S; Sakowicz A; Rowińska-Zakrzewska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():179-89. PubMed ID: 9337536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical value of measurement of serum creatine kinase BB and neuron specific enolase for small cell lung cancer].
    Zhou J; Xiong Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):90-3. PubMed ID: 7657349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical evaluation of serum NSE and CEA in primary lung cancer patients].
    Fukasawa T; Fujisawa T; Yamaguchi Y; Sasaki K; Shiba M; Yusa T; Sakio H; Momiki S; Ogawa T
    Gan To Kagaku Ryoho; 1986 May; 13(5):1862-7. PubMed ID: 3010884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
    Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
    Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pro-gastrin-releasing peptide (ProGRP), neuron specific enolase (NSE), carcinoembryonic antigen (CEA) and cytokeratin 19-fragments (CYFRA 21-1) in patients with lung cancer in comparison to other lung diseases.
    Schneider J; Philipp M; Velcovsky HG; Morr H; Katz N
    Anticancer Res; 2003; 23(2A):885-93. PubMed ID: 12820318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Level of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of small cell lung cancer patients: correlation with performance status, disease extent and prognosis].
    Szturmowicz M; Rogińska E; Roszkowski K; Kwiek S; Filipecki S; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1993; 61(9-10):467-73. PubMed ID: 8111322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.
    Graziano SL; Tatum AH; Newman NB; Oler A; Kohman LJ; Veit LJ; Gamble GP; Coleman MJ; Barmada S; O'Lear S
    Cancer Res; 1994 Jun; 54(11):2908-13. PubMed ID: 8187076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative analysis of serum levels of CA-50, CA-125, CA-19.9, enolase and CEA in bronchopulmonary cancer].
    Maréchal F; Deltour G; Incatasciato C; Carpentier Y; Cattan A
    Rev Pneumol Clin; 1987; 43(5):224-8. PubMed ID: 2829332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
    De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
    [No Abstract]   [Full Text] [Related]  

  • 36. Value of tumour and inflammatory markers in lung cancer.
    Oremek GM; Sauer-Eppel H; Bruzdziak TH
    Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Measurement of carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific enolase in the bronchoalveolar lavage fluid in patients with peripheral lung cancer].
    Fujii M; Kiura K; Kamei H; Segawa Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Apr; 27(4):452-5. PubMed ID: 2552209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The diagnostic values of CA242 combining other tumor markers for lung cancer].
    Zhang S; Ma Y; Yang X
    Zhonghua Jie He He Hu Xi Za Zhi; 1999 May; 22(5):271-3. PubMed ID: 11775851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical study of small cell lung carcinoma; with special reference to the neuroendocrine markers aromatic L-amino acid decarboxylase and gastrin-releasing peptide.
    Nakajima T; Shimosato Y; Morinaga S; Terasaki T; Tsumuraya M; Yamaguchi K; Ichinose H; Nagatsu T; Kato K; Nakazato Y
    Jpn J Clin Oncol; 1986 Sep; 16(3):223-33. PubMed ID: 2430122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.